Genetic origins and clinical phenotype of familial and acquired erythrocytosis and thrombocytosis

Am J Hematol. 2009 Jan;84(1):46-54. doi: 10.1002/ajh.21313.

Abstract

Familial and acquired erythrocytosis and thrombocytosis are characterized by myeloid lineage hyperproliferation, which is either single or multi-lineage in origin. The single lineage disorders exhibit Mendelian inheritance with polyclonal hematopoiesis and often arise from a single genetic defect. In contrast, the multi-lineage disorders exhibit complex patterns of inheritance with multi-genetic origins and clonal hematopoiesis. They have the potential to acquire JAK2 somatic mutations, but this is not the primary event. Identification of the disease-causing genes will enable better classification of familial and acquired erythrocytosis and thrombocytosis. Furthermore, it will provide an insight into the mechanisms regulating myeloid cell proliferation.

Publication types

  • Review

MeSH terms

  • Basic Helix-Loop-Helix Transcription Factors / genetics
  • Genetic Predisposition to Disease / genetics*
  • Humans
  • Hypoxia-Inducible Factor-Proline Dioxygenases
  • Polycythemia Vera / genetics*
  • Procollagen-Proline Dioxygenase / genetics
  • Thrombocytosis / genetics*
  • Thrombopoietin / genetics
  • Von Hippel-Lindau Tumor Suppressor Protein / genetics

Substances

  • Basic Helix-Loop-Helix Transcription Factors
  • endothelial PAS domain-containing protein 1
  • Thrombopoietin
  • EGLN1 protein, human
  • Procollagen-Proline Dioxygenase
  • Hypoxia-Inducible Factor-Proline Dioxygenases
  • Von Hippel-Lindau Tumor Suppressor Protein
  • VHL protein, human